2025 revenue consensus $438.17M. Narrows 2025 adjusted EBITDA view to $88M-$91M vs. $86M-$91M.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AORT:
- Artivion announces treatment of first patient in ARTIZEN pivotal trial
- AORT Upcoming Earnings Report: What to Expect?
- Artivion Inc. Advances Aortic Treatment with New Clinical Study
- Artivion announces data from AMDS PERSEVERE and PROTECT trials
- Artivion price target raised to $47 from $42 at Citizens JMP